Dai H, Chang L, Yang S, Wang S, Su S, Yeh Y. HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability. Neoplasia. 2023;35:100845 pubmed publisher

Nomura Y, Nakano M, Woo Sung H, Han M, Pandey D. Inhibition of HDAC6 Activity Protects Against Endothelial Dysfunction and Atherogenesis in vivo: A Role for HDAC6 Neddylation. Front Physiol. 2021;12:675724 pubmed publisher

Magupalli V, Negro R, Tian Y, Hauenstein A, Di Caprio G, Skillern W, et al. HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation. Science. 2020;369: pubmed publisher

Chi Z, Le T, Lee S, Guo E, Kim D, Lee S, et al. Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine γ-lyase degradation. J Cell Mol Med. 2020;: pubmed publisher

Chen H, Qian Y, Chen X, Ruan Z, Ye Y, Chen H, et al. HDAC6 Restricts Influenza A Virus by Deacetylation of the RNA Polymerase PA Subunit. J Virol. 2019;93: pubmed publisher

Bitler B, Wu S, Park P, Hai Y, Aird K, Wang Y, et al. ARID1A-mutated ovarian cancers depend on HDAC6 activity. Nat Cell Biol. 2017;19:962-973 pubmed publisher

Salemi L, Maitland M, Yefet E, Schild Poulter C. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex. BMC Cancer. 2017;17:460 pubmed publisher

Schoepflin Z, Shapiro I, Risbud M. Class I and IIa HDACs Mediate HIF-1? Stability Through PHD2-Dependent Mechanism, While HDAC6, a Class IIb Member, Promotes HIF-1? Transcriptional Activity in Nucleus Pulposus Cells of the Intervertebral Disc. J Bone Miner Res. 2016;31:1287-99 pubmed publisher

Kawaguchi Y, Kovacs J, McLaurin A, Vance J, Ito A, Yao T. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 2003;115:727-38 pubmed